Approval · Notice of Compliance 466 · 2003
RESCRIPTOR: Notice of Compliance 466
Issued September 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 466
- Date
- September 11, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESCRIPTOR | 02238348 | Cancelled Post Market |
Medicinal ingredients
- DELAVIRDINE MESYLATE 100 MG per TAB